SGN timeline
Every SGN batch the index holds, newest manufacture date first, with the supplier's declared purity beside the median of the index's independent observations of the same lot.
| Lot | Compound | Manufactured | Quarter | Tests | Independent median | Spread (pp) | COA purity | Divergence (pp) | |
|---|---|---|---|---|---|---|---|---|---|
| SGN-2605-X9069 | ARA-290 | 24 May 2026 | 2026-Q2 | 12 | 98.31 | 1.29 | 98.69 | +0.38 | |
| SGN-2603-X8452 | GHK-Cu | 26 Mar 2026 | 2026-Q2 | 12 | 98.22 | 1.17 | 98.23 | +0.01 | |
| SGN-2602-X9377 | SLU-PP-332 | 28 Feb 2026 | 2026-Q2 | 6 | 98.42 | 0.72 | 98.66 | +0.24 | |
| SGN-2602-Y9306 | Afamelanotide | 25 Feb 2026 | 2026-Q3 | 2 | 99.35 | 1.17 | 99.31 | -0.04 | |
| SGN-2512-Y9621 | Thymosin α1 | 16 Dec 2025 | 2026-Q2 | 1 | 99.42 | n<2 | 98.78 | -0.64 | |
| SGN-2510-R8306 | Afamelanotide | 23 Oct 2025 | 2025-Q4 | 9 | 98.37 | 0.67 | 98.92 | +0.55 | |
| SGN-2510-P8974 | GHRP-6 | 08 Oct 2025 | 2026-Q1 | 7 | 98.89 | 1.30 | 99.02 | +0.13 | |
| SGN-2507-F9360 | BPC-157 | 20 Jul 2025 | 2025-Q3 | 9 | 98.59 | 0.77 | 99.03 | +0.44 | |
| SGN-2507-W9570 | Tirzepatide | 18 Jul 2025 | 2025-Q3 | 1 | 98.74 | n<2 | 98.80 | +0.06 | |
| SGN-2506-M8920 | TB-500 | 15 Jun 2025 | 2025-Q3 | 10 | 99.26 | 1.03 | 99.77 | +0.51 | |
| SGN-2506-J8349 | Tirzepatide | 15 Jun 2025 | 2025-Q3 | 17 | 97.65 | 2.09 | 97.57 | -0.08 | |
| SGN-2505-Y8806 | N-Acetyl Semax Amide | 25 May 2025 | 2025-Q3 | 1 | 99.38 | n<2 | 99.51 | +0.13 | |
| SGN-2505-A9025 | PT-141 (Bremelanotide) | 18 May 2025 | 2025-Q3 | 1 | 98.04 | n<2 | 98.66 | +0.62 | SHARED BULK |
| SGN-2505-G9079 | Tirzepatide | 05 May 2025 | 2025-Q4 | 4 | 98.76 | 0.90 | 98.87 | +0.11 | |
| SGN-2504-A9334 | Triptorelin | 30 Apr 2025 | 2025-Q2 | 10 | 98.80 | 1.22 | 98.64 | -0.16 | |
| SGN-2504-P9129 | Thymosin α1 | 17 Apr 2025 | 2025-Q3 | 5 | 99.52 | 0.89 | 99.82 | +0.30 | |
| SGN-2503-S9261 | MGF | 08 Mar 2025 | 2025-Q2 | 3 | 99.39 | 0.13 | 99.49 | +0.10 | |
| SGN-2503-P9641 | Tirzepatide | 05 Mar 2025 | 2025-Q2 | 5 | 97.83 | 0.85 | 98.24 | +0.41 | |
| SGN-2502-Y8340 | Sermorelin | 14 Feb 2025 | 2025-Q3 | 7 | 99.16 | 0.73 | 98.46 | -0.70 | |
| SGN-2502-F9009 | Semaglutide | 13 Feb 2025 | 2025-Q3 | 6 | 99.37 | 0.88 | 99.41 | +0.04 | SHARED BULK |
| SGN-2502-J9369 | Semaglutide | 12 Feb 2025 | 2025-Q2 | 3 | 97.81 | 0.41 | 98.00 | +0.19 | |
| SGN-2502-W8153 | Ipamorelin | 04 Feb 2025 | 2025-Q2 | 2 | 98.66 | 0.14 | 98.65 | -0.01 | |
| SGN-2412-Y9108 | PT-141 (Bremelanotide) | 28 Dec 2024 | 2025-Q1 | 1 | 99.27 | n<2 | 99.00 | -0.27 | |
| SGN-2412-L9210 | CJC-1295 (no DAC) | 15 Dec 2024 | 2025-Q2 | 5 | 99.36 | 0.26 | 98.95 | -0.41 | |
| SGN-2411-N8496 | GHRP-6 | 17 Nov 2024 | 2025-Q1 | 3 | 99.14 | 0.64 | 99.21 | +0.07 | |
| SGN-2411-N9012 | Tirzepatide | 14 Nov 2024 | 2024-Q4 | 14 | 98.99 | 1.24 | 99.55 | +0.56 | |
| SGN-2410-P9125 | L-Glutathione (reduced) | 19 Oct 2024 | 2024-Q4 | 1 | 99.49 | n<2 | 99.29 | -0.20 | |
| SGN-2410-D9265 | Semaglutide | 16 Oct 2024 | 2025-Q1 | 7 | 98.17 | 0.81 | 98.83 | +0.66 | |
| SGN-2409-F8056 | Semaglutide | 30 Sep 2024 | 2024-Q4 | 2 | 98.50 | 0.55 | 98.68 | +0.18 | |
| SGN-2409-E9197 | TB-500 | 27 Sep 2024 | 2024-Q4 | 7 | 99.06 | 0.51 | 99.32 | +0.26 | |
| SGN-2409-H8807 | Selank | 24 Sep 2024 | 2025-Q1 | 7 | 98.28 | 0.32 | 98.55 | +0.27 | |
| SGN-2409-D9295 | IGF-1 LR3 | 06 Sep 2024 | 2025-Q1 | 3 | 98.26 | 0.43 | 99.12 | +0.86 | |
| SGN-2408-S8580 | Tirzepatide | 22 Aug 2024 | 2024-Q4 | 4 | 98.10 | 0.51 | 99.90 | +1.80 | |
| SGN-2408-X9083 | Liraglutide | 10 Aug 2024 | 2024-Q4 | 1 | 98.28 | n<2 | 98.90 | +0.62 | |
| SGN-2407-R9375 | N-Acetyl Semax Amide | 12 Jul 2024 | 2024-Q3 | 12 | 98.56 | 1.06 | 98.86 | +0.30 | |
| SGN-2401-K9783 | Tirzepatide | 31 Jan 2024 | 2024-Q2 | 15 | 98.16 | 1.89 | 98.64 | +0.48 | |
| SGN-2401-B8456 | GHRP-6 | 07 Jan 2024 | 2024-Q1 | 6 | 99.20 | 0.51 | 98.83 | -0.37 |